drugset / Trial / NCT01479595
A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to investigate the efficacy and safety of QBX258 in subjects with moderate to severe asthma.
Timeline
- Start
- 2012-02
- Primary completion
- 2015-02
- Completion
- 2015-02
Outcome
Met primary endpoint
registry p = 0.005; Mean Difference (Net) -0.514 (90% CI -0.811 to -0.217) NCT01479595 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QAX576 | Monoclonal antibody | 6 mg/kg | Intravenous |
| Subject | VAK694 | Unknown | 3 mg/kg | Intravenous |